Advertisement
Representing major specialist organisations and thought leaders in thewound care field, the Systagenix Medical Advisory Board will meet at specificintervals to provide feedback, input and guidance on company clinical andcommercial strategies and their implementation. The group represents a broadsection of the wound care clinical community with multi-disciplinarybackgrounds, including academic and health economic experts, practicingsurgeons, and nurse specialists. As well as advising Systagenix regardingtheir existing portfolio, they will focus on new and emerging technologies aswell as future clinical trends within wound care. They will also advise onother critical issues, such as health economics and reimbursement in order tohelp Systagenix meet the changing needs of the global wound care market.
Advertisement
In addition to clinical and new product development, working with DrSnyder, the Systagenix Medical Advisory Board will also focus on education,including new pathways to help reach and communicate with fellow healthcareprofessionals on the best and most up-to-date wound care practices.
Systagenix was formed by a management buyout of the Johnson & JohnsonProfessional Wound Care business which had a 75 year heritage. Systagenix hasvery clear objectives to become the world's strongest and most admired woundcare company. The new Medical Advisory Board is designed to help the companymeet those objectives by better understanding the needs of the clinician andtheir patients.
Systagenix's CEO, Steve Atkinson comments: "Education, innovation andforward thinking are crucial in the constantly changing and evolving woundcare field. We are delighted to welcome such a prestigious panel of expertsunder the renowned guidance of Dr Snyder, all of whom will help us define andrefine our thinking for future clinical, educational and technologicaldevelopments."
Dr Snyder adds: "With such a varied and experienced panel of experts, weare bound to create new and exciting opportunities to forge ahead withinnovation which is specifically aimed at meeting clinician and patient needsaround the world. I am delighted that the Systagenix Medical Advisory Boardhas been formed and I look forward to working with the group as we seek topioneer new ideas and techniques in wound care across a number of key areas".
Notes to Editors:
Members of the Systagenix Clinical Advisory Board are:
Chair: Dr. Robert Snyder, DPM, CWS: Medical Director, Systagenix;Diplomat, American Board of Podiatric Surgery; Fellow, American College ofFood & Ankle Surgery; Certified Wound Specialist; Medical Director, WoundHealing Centre, University Hospital, Tamarac, Florida; Clinical Professor(Adjunct), Temple University College of Podiatric Medicine; Diplomat,American Academy of Wound Management; serves on the board of directors,Association for the Advancement of Wound Care
Professor David G. Armstrong, DPM, PhD: Professor of Surgery (withTenure), University of Arizona; co-founded the Southern Arizona Limb SalvageAlliance; founder and co-chair of the International Diabetic Food Conference
Professor Dr. Med. Matthias Augustin: Professor for Health Economics &QoL Research Group, Department of Dermatology, University Clinics of Hamburg,Germany
Mona M. Baharestani, PhD, ANP, CWOCN, CWS: Associate Professor &Secretary for the Advancement of Wound Care, Center for Nursing Research,East Tennessee State University, USA; Faculty Professor, Oxford UniversityWound Healing Summer School, UK
Laura Bolton, PhD: Adjunct Associate Professor of the Department ofSurgery, Bioengineering Section, New Jersey, USA; member of Editorial Boardsof Wound Repair and Regeneration, Ostomy/Wound Management, Advances in Skin &Wound Care & WOUNDS publications; co-chairs the Association for theAdvancement of Wound Care Guideline Department
Pr. Frank Duteille, MD: Head of Department of Plastic Reconstructive andEsthetic Surgery, University Hospital, Nantes, France
Dieter Mayer, MD: Vascular Surgeon, EBSQ-VASC, FMH; Senior Consultant ofVascular Surgery & Head of Wound Care, Zurich University Hospital, Switzerland
Zena Moore, PhD, MSc, FFNMRCSI, PG Dip, RGN: Lecturer in Wound Healing &Tissue Repair & Research Methodology, Faculty of Nursing & Midwifery, RoyalCollege of Surgeons in Ireland; Current President of European WoundManagement Association and chair of the education committee
Prof. Marco Romanelli, MD, PhD: Consultant Dermatologist, Department ofDermatology, University of Pisa, Italy; Director Wound Healing Research Unit,University of Pisa; leads a research group actively involved in clinical,laboratory and educational activities
Dr Thomas E. Serena, MD, FACS, FACHM, FAPWCA: Founder & Medical Directorof Pennsylvania North Centers for Advanced Wound Care, USA; founder of theNewBridge Medical Research Corporation and emeritus member of the Board ofDirector of the Wound Healing Society
Prof. Gary Sibbald, BSc, MD, FRCPC (Med) (Derm), ABIM, DABD, MEd:Professor of Public Health Sciences and Medicine, University of Toronto;Director of medical education for Women's College Hospital and Chair of thefaculty of Medical Education Committee; Board member and President of theCanadian Association of Continuing Health Education, University of Toronto,Canada
Dot Weir, RN, CWON, CWS: Director of Wound Care for Osceola RegionalMedical Center, Florida, USA; held posts of Treasurer & President ofAssociation for Advancement of Wound Care
Thomas Wild, MD: Department of Surgery, University of Vienna, Austria;President Elect of Austrian Wound Association
Systagenix Portfolio Details
Professional Advanced Wound Care Products:
ACTISORB(R) Activated Charcoal Dressing with Silver - helps to manageinfection through its unique mode of action that traps and kills bacteria andeliminates malodors. The first commercialized silver dressing available atthe time of its launch in 1980. The safety and efficacy of ACTISORB(R)Dressings is now supported with published clinical evidence in over 13,000patients.
ADAPTIC(R) Non-Adhering Dressing - helps to protect regenerating tissueand minimizes patient pain and trauma during dressing changes.
INADINE(R) PVP-I Non-Adherent Dressing - a topical wound dressingimpregnated with an ointment containing 10% povidone iodine is indicated forthe management of ulcerative wounds and may also be used for the preventionof infection in minor burns and minor traumatic skin loss injuries
NU-GEL(R) Hydrogel with Alginate - a transparent hydro active amorphousgel containing sodium alginate creates a moist wound-healing environment,which assists with natural autolytic debridement and desloughing of wounds.
PROMOGRAN(R) Matrix Dressing - a unique, clinically proven combination ofcollagen and oxidized regenerated cellulose ("ORC"); facilitates tissuegranulation through modulation of the wound environment.
PROMOGRAN PRISMA(TM) Balancing Matrix Dressing - combines collagen andORC with an optimal level of silver; helps restore the normal wound-healingenvironment by reducing bacterial levels without causing harm to host cells.
REGRANEX(R) (becaplermin) Gel 0.01% - a gel containing recombinant humanplatelet derived growth factor; the first and only growth factor approved forclinical use in the U.S. and Europe to heal and close lower extremitydiabetic neuropathic ulcers.
SILVERCEL(R) Anti-microbial Alginate Dressing - provides a controlled,balanced and sustained release of silver that helps manage infection andexudates while offering superior dressing tensile strength for easy, intactremoval.
TIELLE(R) Hydropolymer Dressings - a broad range of foam dressingshandling different levels of exudates to reduce wound maceration and leakagewhile optimizing cost effectiveness through increased dressing wear time.
Professional General Wound Care Products:
TOPPER(R) Drain Swab and TOPPER(R) Non-Woven Fabric Swab - a uniquerayon/polyester, non-woven sponge that provides improved strength,absorbency, and scrubbing texture compared to traditional gauze.
RELEASE(R) Low-Adherent Dressing - utilizes a unique perforated filmdesign that directs exudates away from the wound; minimizes discomfort andtissue damage during dressing changes.
REGAL(R) Filmated Non-Woven Swab - a multi-layer absorbent swab coveredwith a film of viscose fibers to disperse exudates and to provide enhancedabsorption capability.
About Systagenix
Systagenix Wound Management was formed by a management buyout of theJohnson & Johnson Professional Wound Care business which had a 75 yearheritage. Systagenix aims to become the world's strongest and most admiredwound care company. The business has the history and knowledge, and a new,dynamic, energetic and highly informed management team to take it to the nextlevel in the UK and across the globe.
Systagenix manufactures in excess of 30 million wound dressings a month.These are used to treat patients in hospitals, nursing homes and also intheir own homes in over 50 countries. Some of the products are used to treatacute wounds in surgery and accidents, where they are used to protect againstinfection and encourage the wound to heal naturally, while other products,and this is where Systagenix's reputation has been forged and revered, is inadvanced wound care, where the business has created products that activelypromote healing in some of the most challenging wounds that result fromchronic conditions such as diabetes, obesity and vascular disease. It is inthese situations that Systagenix's products are used to save patients fromlimb amputation.
For more information:
Contact Susan Leigh or Gilllian Waddell on +44-(0)207-498-8211
[email protected] or [email protected]
SOURCE Systagenix
